EQT Sells Karo Healthcare to KKR

EQT VIII Sells Galderma Group AG Shares to L'Oréal S.A.

December 8, 2025

Healthcare Services

An affiliate of EQT VIII has signed an agreement to sell approximately 24 million shares in Galderma Group AG to L'Oréal S.A. The transaction is subject to customary regulatory approvals, and the premium was not disclosed.

EQT Infrastructure to Acquire KJ Environment in South Korea

August 16, 2024

Environmental Services

EQT Infrastructure VI has entered into a definitive agreement to acquire KJ Environment and affiliated companies to build an end-to-end waste treatment platform in South Korea focused on plastic recycling and waste-to-energy. The platform will leverage assets in the Greater Seoul Metropolitan Area and is intended to support a scaled and diversified circular economy infrastructure business. Closing is expected in Q4 2024, subject to customary conditions and approvals.

EQT Sells kfzteile24 to Management and Investor Consortium

April 20, 2023

E-Commerce

EQT Mid Market has sold Berlin-headquartered eCommerce platform kfzteile24 to a consortium led by the company's management together with Project A Ventures, Koehler Group and a group of technology investors (SB21). Under EQT's ownership kfzteile24 expanded its product range and logistics capabilities; the transaction closed on 20 April 2023 as an exit by EQT Private Equity.

Karo Pharma Acquires Sylphar International NV

January 13, 2023

Pharmaceuticals

Karo Pharma Aktiebolag has completed the acquisition of Belgian digital-first consumer health brand company Sylphar International NV for EUR 290 million. The deal is intended to strengthen Karo's market position and digital commerce capabilities; Sylphar CEO Robin List will join Karo's corporate management team and continue to lead Sylphar operations.

EQT Private Equity and Goldman Sachs Asset Management Acquire Parexel from Pamplona Capital Management

July 2, 2021

Healthcare Services

EQT Private Equity (EQT IX) and Goldman Sachs Asset Management's Private Equity business have agreed to acquire Parexel from Pamplona Capital Management for an enterprise value of USD 8.5 billion. Parexel, a global clinical research organization co-headquartered in Durham, North Carolina and Newton, Massachusetts, employs more than 17,000 people and provides outsourced clinical development, regulatory, market access and consulting services to the pharma and biotech industry.

EQT Acquires Mabtech from IK Partners and Mérieux Equity Partners

January 9, 2024

Biotechnology

EQT, via its newly launched EQT Healthcare Growth Strategy, is acquiring Swedish immunoassay specialist Mabtech AB from IK Partners and Mérieux Equity Partners. Mabtech, a developer and manufacturer of antibodies, kits and readers used in vaccine, infectious disease and oncology research, will be supported by EQT to expand its product portfolio and accelerate geographic growth, particularly in the US. The transaction is subject to customary regulatory approvals and financial terms were not disclosed.